Ocugen, Inc. Announces Pricing of $53.5 Million Public Offering of Common Stock
Ocugen, Inc. Announces Pricing of $53.5 Million Public Offering of Common Stock MALVERN, Pa., Feb 22, 2022 (GLOBE NEWSWIRE via COMTEX) — Ocugen, Inc. (Nasdaq: OCGN), a clinical-stage biopharmaceutical company […]
Ocugen, Inc. Announces Pricing of $53.5 Million Public Offering of Common Stock Read More »